Haemato

HAE-DE:ETR

Pharmaceuticals: Generic

Market Cap

—

MICRO cap

Share Price ←

(—)

YTD Return ←

—

since start of 2021

P/E Ratio

—

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

About

Pharmaceuticals: Generic Founded 1993

Haemato AG engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes generics for aids, neurology, oncology, rheumatology, and urology diseases. The company was founded on May 10, 1993 and is headquartered in Schönefeld, Germany.

website

Headquarters

Lilienthalstraße 5c

Schönefeld, Brandenburg 12529

49.30.897.30.86.70

Executives

Name	Title	Gender
Andrea Grosse	Chairman-Supervisory Board	Female

Mindful Investing Summary

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

— N/A

Haemato - Competitors and Related Companies

How Haemato stacks up to its peers in the Pharmaceuticals: Generic industry or with competing business segments.